Kidney Disease: Two Cheap Tests Catch What Symptoms Miss

Doctor holding digital illustration of human kidneys — Photo: Natali _ Mis / Shutterstock

Kidney disease can quietly damage your body for years before you feel a single symptom, which is exactly why two cheap, routine tests matter so much.

Quick Take

Two simple tests, a blood check called eGFR and a urine test called uACR, can catch kidney disease early, according to major health guidelines.
An estimated 844 million adults worldwide live with chronic kidney disease, and many don’t know it yet.
Kidney damage often shows no symptoms in its early stages, making routine testing the main way to catch it.
Doctors group these tests as most useful for people with diabetes, high blood pressure, or other risk factors, not as a universal screen for everyone.

The Two Tests Doctors Actually Trust

Kidney experts agree on a simple formula for catching chronic kidney disease early. The 2024 KDIGO clinical practice guideline tells doctors to test at-risk patients using both a urine albumin measurement and an estimate of glomerular filtration rate, known as GFR. The National Kidney Foundation describes the same pair in plain terms: a blood test called eGFR and a urine test called the urine albumin-creatinine ratio, or uACR.

These aren’t competing tests. They measure different things. The eGFR blood test estimates how well your kidneys filter waste out of your blood. The uACR urine test checks for a protein called albumin that shouldn’t normally leak into urine. When it does, that’s often an early sign of kidney damage, sometimes years before a person feels sick.

Why Symptoms Show Up Too Late

Chronic kidney disease earns its nickname as a silent condition for a reason. Damage can build for years while a person feels completely normal. That’s why guidelines push testing instead of waiting for symptoms. Government health guidance from British Columbia recommends screening high-risk patients with both eGFR and urine ACR precisely because symptoms arrive too late to help with early treatment.

A single odd result doesn’t mean a diagnosis, though. Guidelines are clear that one abnormal reading should be repeated before anyone concludes a patient has chronic kidney disease. The condition requires signs of damage or reduced function lasting at least three months, plus follow-up to sort out the cause and severity. That distinction matters. A blood or urine test that flags a problem is a starting point for more conversation with a doctor, not a final verdict.

Who Actually Needs These Tests

Not every adult needs to run out and demand both tests tomorrow. The strongest evidence and cost-effectiveness data point to people with diabetes and high blood pressure, the two biggest drivers of kidney damage. One systematic review found screening was cost-effective in nearly all diabetic patients and a strong majority of those with hypertension, while benefits for the general population were far less certain.

That nuance gets lost easily in health headlines promising simple answers. The U.S. Preventive Services Task Force has said there isn’t enough direct trial evidence to recommend routine screening for kidney disease in adults without symptoms or risk factors. That’s not a knock on the tests themselves. It’s a reminder that smart medicine targets people who are actually at risk, rather than turning every checkup into a blanket screening spree that could rack up costs and false alarms without proven benefit.

The Bigger Picture on Underdiagnosis

Despite the debate over who should be screened, one fact stands out: chronic kidney disease remains badly underdiagnosed. Research shows diagnosis rates climb sharply as kidney function drops, jumping from about 22 percent in patients with early warning signs to nearly 88 percent once the disease reaches its most severe stage. That gap suggests many people with early damage are walking around unaware, missing the window when lifestyle changes and treatment do the most good.

For readers with diabetes, high blood pressure, a family history of kidney problems, or who are simply over 40 and haven’t had bloodwork in years, asking a doctor about eGFR and uACR is a reasonable, low-cost move. The tests are inexpensive, widely available, and backed by every major kidney guideline in the world. Whether that translates into better long-term health depends on catching problems early and following through, but the first step is simply knowing your numbers.